Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Nephros (NEPH) Net Income towards Common Stockholders (2016 - 2025)

Historic Net Income towards Common Stockholders for Nephros (NEPH) over the last 17 years, with Q3 2025 value amounting to $337000.0.

  • Nephros' Net Income towards Common Stockholders rose 8415.3% to $337000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.5 million, marking a year-over-year increase of 26207.26%. This contributed to the annual value of $74000.0 for FY2024, which is 10469.84% up from last year.
  • As of Q3 2025, Nephros' Net Income towards Common Stockholders stood at $337000.0, which was up 8415.3% from $237000.0 recorded in Q2 2025.
  • Nephros' 5-year Net Income towards Common Stockholders high stood at $579000.0 for Q1 2025, and its period low was -$3.2 million during Q3 2022.
  • For the 5-year period, Nephros' Net Income towards Common Stockholders averaged around -$622578.9, with its median value being -$433000.0 (2023).
  • In the last 5 years, Nephros' Net Income towards Common Stockholders crashed by 24060.4% in 2022 and then soared by 42897.73% in 2025.
  • Quarter analysis of 5 years shows Nephros' Net Income towards Common Stockholders stood at -$1.1 million in 2021, then grew by 16.77% to -$918000.0 in 2022, then grew by 28.76% to -$654000.0 in 2023, then skyrocketed by 155.66% to $364000.0 in 2024, then fell by 7.42% to $337000.0 in 2025.
  • Its last three reported values are $337000.0 in Q3 2025, $237000.0 for Q2 2025, and $579000.0 during Q1 2025.